Quick Takeaways
- Christopher James Stevens has 1 issuer position tracked on this page.
- Estimated disclosed ownership value: $1,782,690.
- Recent insider filing activity is available below.
Insider Trading & Ownership of Christopher James Stevens
- Location
- Cranbury, NJ
- Summary
- The estimated net worth of Christopher James Stevens is at least $1,782,690 dollars as of 13 Feb 2026. Christopher James Stevens is the Chief Operating Officer of ROCKET PHARMACEUTICALS, INC. and owns shares of ROCKET PHARMACEUTICALS, INC. (RCKT) stock worth about $1.78M.
- Signature
- /s/ Martin Wilson, as attorney-in-fact for Christopher James Stevens
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Christopher James Stevens and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
What Changed
- Largest disclosed position: ROCKET PHARMACEUTICALS, INC. ($1,782,690).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Christopher James Stevens
RCKT, RCKTW
Forms 3/4/5
ROCKET PHARMACEUTICALS, INC.
- Relationship
- Chief Operating Officer
- Holdings value
- $1,782,690
- Past year net change
- Change %
- Report period
- 11 Feb 2026
Insider Transactions Reported by Christopher James Stevens:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.